If SPL is to succeed then SPL needs to start performing.
Until that happens, I will hold them to account.
I am not rubbishing those tests at all, but remember those tests are not in human and those tests are not enough to gain approvals in most jurisdictions. Typically a test conducted by Scripps would guide a company in their decision as to whether to push into clinical trials.
In this instance SPL chose not to conduct clinical trials. Aaaaaaaaaaand here we are.
At the end of the day I am sure that VIRALEZE works. BUT for it to be approved for use it needs to go through adequate trials. SPL chose not to do this.
Covid-19 is not over by a long shot ladies and gentlemen, page-43
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $70.99K | 620.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 337138 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 116759 | 6 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 11.5¢ | 11.0¢ | 165069 | ||
| Last updated 15.30pm 17/05/2024 ? | |||||
| SPL (ASX) Chart |